Loblaw Companies has sold a healthcare software company it agreed to buy for approximately $170 million a decade ago, transferring a widely used Canadian medical records platform to a private equity-backed firm without revealing what it received in return.
The sale moves QHR Technologies, developer of the Accuro electronic medical records system, from Loblaw’s Shoppers Drug Mart division to Montreal-based LGI Healthcare Solutions. Accuro supports approximately 25,000 healthcare providers, according to LGI.
Shoppers will retain a commercial and strategic relationship with the buyer, although neither party disclosed its financial terms.
When Loblaw announced its agreement to acquire QHR in August 2016, it offered $3.10 per share, valuing the transaction at roughly $170 million. Its 2016 annual report subsequently recorded approximately $167 million in cash consideration, with the acquisition closing on October 13, 2016.
Loblaw then said QHR supported 7,700 healthcare providers. LGI now reports approximately 25,000 providers using Accuro, although the historical and current counts are described differently and cannot automatically be treated as a like-for-like measure of growth.
LGI’s new reach extends from hospital and long-term care software into community-based primary care, including general practitioners, specialists, and allied health professionals. The company is listed as a current investment by Canadian private equity firm Novacap, which acquired LGI’s predecessor Logibec alongside Investissement Québec in 2020.
Shoppers is not exiting healthcare services. The disclosure lists more than 1,350 Shoppers Drug Mart and Pharmaprix stores and identifies its continued ownership of Lifemark Health Group and other healthcare businesses. What it has relinquished is ownership of QHR, not its broader healthcare operations.
The transaction also raises a specific governance issue. QHR’s publicly available privacy policy says Loblaw’s privacy office manages QHR’s privacy program and still identifies Loblaw as its parent.
The companies have not said whether that administrative relationship will continue or be replaced following the sale.
The same policy states that healthcare providers remain custodians of their patients’ personal health information.
LGI says existing Accuro customers will retain their dedicated support teams and that it plans continued investment in software, including responsible AI. It has not announced new arrangements for using identifiable patient data.